BPI-1831

N/A

Report date: 2023/02/06 11:25:20
NME

Base Information

Drug NameBPI-1831
Drug Alias NameBPI-1831
ClassificationSmall molecules
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeta Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeta Pharma Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A